74
Participants
Start Date
January 31, 2007
Primary Completion Date
December 31, 2011
Study Completion Date
February 29, 2012
labetalol/hydralazine/enalapril
Blood pressure will be treated with intravenous labetalol (10 mg starting dose)/hydralazine (5 mg starting dose)/enalapril (1.25 mg starting dose).
University of Calgary, Calgary
University of Ottawa, Ottawa
University of Alberta, Edmonton
Grey Nuns Hospital, Edmonton
Heart and Stroke Foundation of Canada
OTHER
Alberta Heritage Foundation for Medical Research
OTHER
University of Alberta
OTHER